Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence, Pattern, and Associated Factors of Alcohol Use Disorder Among Male Treatment-Seeking People With Illicit Drug Use Disorder in Tehran, Iran Publisher



Rafiemanesh H1 ; Rahimimovaghar A2 ; Shadloo B2 ; Rostamabadi Y2 ; Nedjat S3 ; Yazdani K3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Epidemiology and Biostatistics, Alborz University of Medical Sciences, Karaj, Iran
  2. 2. Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Substance Use Published:2023


Abstract

Background: Comorbid alcohol and illicit drug use disorder is relatively prevalent. We aimed to assess the prevalence, pattern, and associated factors of alcohol use disorder among treatment-seeking individuals with drug use disorders in Iran. Methods: This was a cross-sectional study, conducted on 387 male patients from residential drug treatment centers in Tehran, Iran. The alcohol module from the Composite International Diagnostic Interview (CIDI 2.1) was used to assess alcohol use disorder.Logistic regression analyses were used to assess the determinants. Results: The main drug of use was opioids, stimulants, and both among 78.0%, 32.3%, and 10.3% of the participants, respectively. The lifetime prevalence of alcohol dependence, harmful use, and hazardous use were 50.6%, 18.3%, and 22.0%, respectively. The past 12-month prevalence was 17.1% for alcohol dependence, 23.0% for harmful use, and 14.7% for hazardous use. Multivariable regression analysis showed that alcohol use by friends (OR = 3.8) and use of stimulants as the main drug (OR = 1.9) were significantly associated with alcohol use disorder. Conclusion: The prevalence of alcohol use disorder was relatively high among males who used drugs. It seems comorbid alcohol and illicit drug use disorder is of utter importance and has been neglected in Iran. © 2022 Taylor & Francis Group, LLC.
Related Docs
View other Related Docs
1. Hepatitis B Virus Infection Among People Who Use Drugs in Iran: A Systematic Review, Meta-Analysis, and Trend Analysis, Harm Reduction Journal (2020)
2. Opium Dependence and the Potential Impact of Changes in Treatment Coverage Level: A Dynamic Modeling Study, Health Promotion Perspectives (2021)
3. Mental Health and Prevention of Substance Use Programs in Iran: Component of the National Action Plan for Prevention and Control of Non-Communicable Diseases, Medical Journal of the Islamic Republic of Iran (2022)
4. Prevalence of Alcohol Consumption Among Clients of Opioid Agonist Treatment (Oat) Centers in Golestan Province, Iran, Frontiers in Psychiatry (2023)
5. Comparison of Self-Reported Substance Use With Biological Testing Among Treatment-Seeking Patients With Opioid Use Disorder, Journal of Substance Abuse Treatment (2022)
6. Population Size Estimation of People Who Use Illicit Drugs and Alcohol in Iran (2015-2016), International Journal of Health Policy and Management (2023)
7. Alcohol Use Disorders in Iran: Prevalence, Symptoms, Correlates, and Comorbidity, Drug and Alcohol Dependence (2017)
8. Public Health Risks Associated With Methadone in Iran: A Systematic Review and Meta-Analysis, International Journal of Drug Policy (2022)
Experts (# of related papers)
View all Related Experts
Afarin Rahimi-Movaghar (15)
Alireza Noroozi (13)
Other Related Docs
9. Buprenorphine Abuse and Health Risks in Iran: A Systematic Review, Drug and Alcohol Dependence (2021)
10. Psychiatric Disorders Among People Living With Hiv/Aids in Iran: Prevalence, Severity, Service Utilization and Unmet Mental Health Needs, Journal of Psychosomatic Research (2018)
11. Alcohol Use Disorders Identification Test (Audit): Validation of the Persian Version in an Iranian Population, Alcohol (2020)
12. Evaluation of a Training Program in General Practitioners’ Attitude Toward the Integration of Substance Use Disorders Services in Primary Health Care, Iranian Journal of Psychiatry and Behavioral Sciences (2022)
13. Factors Influencing Engagement and Utilisation of Opium Tincture-Assisted Treatment for Opioid Use Disorder: A Qualitative Study in Tehran, Iran, Drug and Alcohol Review (2022)
14. Non-Communicable Diseases’ Risk Factors in Iran; a Review of the Present Status and Action Plans, Journal of Diabetes and Metabolic Disorders (2021)
15. Prevalence and Correlates of Lifetime Alcohol Use Among Adult Urban Populations in Iran: A Knowledge, Attitude, and Practice Study, Journal of Psychoactive Drugs (2019)
16. A Public Health Approach to Alcohol Use and Its Related Harms in Iran, The Lancet Public Health (2019)
17. Age- and Sex-Standardized Prevalence of Alcohol Consumption and Its Determinants in the Western Region of Iran, Ilam: A Cross-Sectional Study, BMC Public Health (2024)
18. Hiv Prevalence Among Non-Injecting People Who Use Drugs and Related Factors in Iran: A Systematic Review and Meta-Analysis, Drug and Alcohol Review (2022)
19. Covid-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. an International Society of Addiction Medicine Practice and Policy Interest Group Position Paper, Basic and Clinical Neuroscience (2020)
20. Retention Rate in Methadone Maintenance Treatment and Factors Associated Among Referred Patients From the Compulsory Residential Centers Compared to Voluntary Patients, Frontiers in Psychiatry (2023)
21. Characterizing People Who Inject Drugs With No History of Opioid Agonist Therapy Uptake in Iran: Results From a National Bio-Behavioural Surveillance Survey in 2020, International Journal of Mental Health and Addiction (2022)
22. Blended Smartphone Intervention for Patients in Opioid Maintenance Treatment in Iran: Protocol for a Randomized Controlled Trial, BMC Psychiatry (2023)
23. Status of Alcohol Consumption Based on the Self-Report of Iran's Industrial Staff, Iranian Journal of Epidemiology (2020)
24. Social Capital of Parents of Children and Adolescents and Its Relation to Psychiatric Disorders; a Population-Based Study, Community Mental Health Journal (2022)
25. Alcohol Treatment Systems in Muslim Majority Countries: Case Study of Alcohol Treatment Policy in Iran, International Journal of Drug Policy (2020)
26. The Prevalence and Determinants of Alcohol Use in the Adult Population of Tehran: Insights From the Tehran Cohort Study (Tecs), Clinical and Experimental Medicine (2025)
27. Public Injecting and Its Association With Mental Health and Other Drug-Related Outcomes Among People Who Inject Drugs in Iran, Journal of Substance Abuse Treatment (2022)
28. Opium Tincture Versus Methadone for Opioid Agonist Treatment: A Randomized Controlled Trial, Addiction (2023)
29. Results From the First Inpatient Alcohol Withdrawal Management Program in Iran: An Observational Study, Alcohol (2020)
30. Alcohol Use, Alcohol Use Disorder and Heavy Episodic Drinking in the Eastern Mediterranean Region: A Systematic Review, Addiction (2024)
31. Association of Abcb1, Μ-Opioid Receptor, and Cytochrome P450 Genes With Methadone Dose in Iranian Male Addicts Under Methadone Therapy, Basic and Clinical Neuroscience (2024)
32. Mortality and Negative Outcomes of Opioid Use and Opioid Use Disorder: A 6-Year Follow-Up Study, Addiction (2022)
33. Pattern of Substance Use Among Students of Medical Sciences in Tehran, Iran: A Latent Class Analysis, Journal of Substance Use (2018)
34. Methods for Calculation of Per Capita Alcohol Consumption in a Muslim Majority Country With a Very Low Drinking Level: Findings From the 2011 Iranian Mental Health Survey, Drug and Alcohol Review (2018)